ChemAnalyst

According to ChemAnalyst, The Zidovudine Prices recorded an upward movement across major pharmaceutical markets during the second quarter of 2026. Price developments were shaped by firm demand for HIV treatment medicines, higher production costs, fluctuations in energy expenses, and changing raw material economics. Zidovudine, also known as azidothymidine (AZT), remains an established nucleoside reverse transcriptase inhibitor (NRTI) used as part of antiretroviral treatment r

According to ChemAnalyst, global Zidovudine prices recorded a significant upward trend across key markets during the first quarter of 2026, supported by increasing production expenses, ongoing supply chain challenges, and steady demand from the pharmaceutical industry. As a vital antiretroviral drug widely used in the treatment and prevention of HIV, Zidovudine continues to play an essential role in healthcare systems worldwide. Throughout the quarter, market participants clo